CDT

CDT Equity Inc.

Healthcare · Biotechnology

$112.83 sample

-0.19 (-0.17%) 1D

Market cap

$483.1B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-07

Alerts

8

Price$112.83 +5.94% 3M daily closessample

113.91102.60

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29INSInsider sell: Chief Financial Officer
Sep 18INSInsider buy: EVP, Operations
Sep 11INSInsider sell: EVP, Operations
Sep 07SEC10-Q filed
Aug 27INSInsider sell: Chief Financial Officer
Aug 18INSInsider sell: General Counsel
Aug 10INSInsider sell: Chief Executive Officer
Aug 04INSInsider sell: Chief Financial Officer

Sign up to see the real CDT record →

Company facts

SEC EDGAR registration

Name: CDT Equity Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -3sample, -100 to +100
Reporting currency: USD

Who is positioning in CDT

sample

Insiders: 16 insider transactions over 90 days, net selling, $605.7M
Congress: 5 members traded over 90 days
Institutions · 13F: 37 funds hold $12.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$25.1B +17.4% y/y

Q4 2024Q3 2026

Inventory$14.8B +12.0% y/y

Q4 2024Q3 2026

Accounts receivable$11.2B +11.9% y/y

Q4 2024Q3 2026

Total debt$28.7B +4.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $67.1B +8.2% 3M
Sample peer B: $440.4B -7.8% 3M
Sample peer C: $447.7B +14.9% 3M
Sample peer D: $133.4B +7.5% 3M
Sample peer E: $50.2B +14.5% 3M